Pharma & Healthcare

Global Sickle Cell Anemia Therapeutics Market Research Report 2026

This report delivers a comprehensive overview of the global Sickle Cell Anemia Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sickle Cell Anemia Therapeutics. The Sickle Cell Anemia Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sickle Cell Anemia Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sickle Cell Anemia Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Emmaus Medical
Theravia
Pfizer
Novartis
Bluebird Bio
Novo Nordisk
Gamida Cell
CRISPR Therapeutics
GlycoMimetics
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Segment by Type
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
Segment by Application
Child
Adult
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sickle Cell Anemia Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by Application
1.3.1 Global Sickle Cell Anemia Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Child
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2021–2032)
2.2 Global Sickle Cell Anemia Therapeutics Growth Trends by Region
2.2.1 Global Sickle Cell Anemia Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Sickle Cell Anemia Therapeutics Market Dynamics
2.3.1 Sickle Cell Anemia Therapeutics Industry Trends
2.3.2 Sickle Cell Anemia Therapeutics Market Drivers
2.3.3 Sickle Cell Anemia Therapeutics Market Challenges
2.3.4 Sickle Cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue
3.1.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Sickle Cell Anemia Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Sickle Cell Anemia Therapeutics Revenue
3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2025
3.5 Global Key Players of Sickle Cell Anemia Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Sickle Cell Anemia Therapeutics, Products and Applications
3.7 Global Key Players of Sickle Cell Anemia Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Sickle Cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2027–2032)
5 Sickle Cell Anemia Therapeutics Breakdown Data by Application
5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Sickle Cell Anemia Therapeutics Market Size (2021–2032)
6.2 North America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)
6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2021–2032)
7.2 Europe Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)
7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Sickle Cell Anemia Therapeutics Market Size (2021–2032)
9.2 Latin America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.1.5 Emmaus Medical Recent Development
11.2 Theravia
11.2.1 Theravia Company Details
11.2.2 Theravia Business Overview
11.2.3 Theravia Sickle Cell Anemia Therapeutics Introduction
11.2.4 Theravia Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.2.5 Theravia Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Sickle Cell Anemia Therapeutics Introduction
11.3.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Sickle Cell Anemia Therapeutics Introduction
11.4.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Bluebird Bio
11.5.1 Bluebird Bio Company Details
11.5.2 Bluebird Bio Business Overview
11.5.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction
11.5.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.5.5 Bluebird Bio Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Sickle Cell Anemia Therapeutics Introduction
11.6.4 Novo Nordisk Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.6.5 Novo Nordisk Recent Development
11.7 Gamida Cell
11.7.1 Gamida Cell Company Details
11.7.2 Gamida Cell Business Overview
11.7.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction
11.7.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.7.5 Gamida Cell Recent Development
11.8 CRISPR Therapeutics
11.8.1 CRISPR Therapeutics Company Details
11.8.2 CRISPR Therapeutics Business Overview
11.8.3 CRISPR Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.8.4 CRISPR Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.8.5 CRISPR Therapeutics Recent Development
11.9 GlycoMimetics
11.9.1 GlycoMimetics Company Details
11.9.2 GlycoMimetics Business Overview
11.9.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction
11.9.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.9.5 GlycoMimetics Recent Development
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.10.5 Prolong Pharmaceuticals Recent Development
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.11.5 Modus Therapeutics Recent Development
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.12.5 Sangamo Biosciences Recent Development
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.13.5 Bioverativ Recent Development
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction
11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.14.5 Imara Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)
11.15.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2021–2026)
Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2027–2032)
Table 11. Sickle Cell Anemia Therapeutics Market Trends
Table 12. Sickle Cell Anemia Therapeutics Market Drivers
Table 13. Sickle Cell Anemia Therapeutics Market Challenges
Table 14. Sickle Cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 16. Global Sickle Cell Anemia Therapeutics Market Share by Players (2021–2026)
Table 17. Global Top Sickle Cell Anemia Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sickle Cell Anemia Therapeutics Revenue, 2025
Table 18. Ranking of Global Top Sickle Cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Sickle Cell Anemia Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Sickle Cell Anemia Therapeutics, Products and Applications
Table 22. Global Key Players of Sickle Cell Anemia Therapeutics, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2021–2026)
Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2027–2032)
Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 29. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2021–2026)
Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2027–2032)
Table 32. North America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 47. Emmaus Medical Company Details
Table 48. Emmaus Medical Business Overview
Table 49. Emmaus Medical Sickle Cell Anemia Therapeutics Product
Table 50. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 51. Emmaus Medical Recent Development
Table 52. Theravia Company Details
Table 53. Theravia Business Overview
Table 54. Theravia Sickle Cell Anemia Therapeutics Product
Table 55. Theravia Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 56. Theravia Recent Development
Table 57. Pfizer Company Details
Table 58. Pfizer Business Overview
Table 59. Pfizer Sickle Cell Anemia Therapeutics Product
Table 60. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 61. Pfizer Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Sickle Cell Anemia Therapeutics Product
Table 65. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 66. Novartis Recent Development
Table 67. Bluebird Bio Company Details
Table 68. Bluebird Bio Business Overview
Table 69. Bluebird Bio Sickle Cell Anemia Therapeutics Product
Table 70. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 71. Bluebird Bio Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Sickle Cell Anemia Therapeutics Product
Table 75. Novo Nordisk Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 76. Novo Nordisk Recent Development
Table 77. Gamida Cell Company Details
Table 78. Gamida Cell Business Overview
Table 79. Gamida Cell Sickle Cell Anemia Therapeutics Product
Table 80. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 81. Gamida Cell Recent Development
Table 82. CRISPR Therapeutics Company Details
Table 83. CRISPR Therapeutics Business Overview
Table 84. CRISPR Therapeutics Sickle Cell Anemia Therapeutics Product
Table 85. CRISPR Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 86. CRISPR Therapeutics Recent Development
Table 87. GlycoMimetics Company Details
Table 88. GlycoMimetics Business Overview
Table 89. GlycoMimetics Sickle Cell Anemia Therapeutics Product
Table 90. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 91. GlycoMimetics Recent Development
Table 92. Prolong Pharmaceuticals Company Details
Table 93. Prolong Pharmaceuticals Business Overview
Table 94. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 95. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 96. Prolong Pharmaceuticals Recent Development
Table 97. Modus Therapeutics Company Details
Table 98. Modus Therapeutics Business Overview
Table 99. Modus Therapeutics Sickle Cell Anemia Therapeutics Product
Table 100. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 101. Modus Therapeutics Recent Development
Table 102. Sangamo Biosciences Company Details
Table 103. Sangamo Biosciences Business Overview
Table 104. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product
Table 105. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 106. Sangamo Biosciences Recent Development
Table 107. Bioverativ Company Details
Table 108. Bioverativ Business Overview
Table 109. Bioverativ Sickle Cell Anemia Therapeutics Product
Table 110. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 111. Bioverativ Recent Development
Table 112. Imara Company Details
Table 113. Imara Business Overview
Table 114. Imara Sickle Cell Anemia Therapeutics Product
Table 115. Imara Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 116. Imara Recent Development
Table 117. Ironwood Pharmaceuticals Company Details
Table 118. Ironwood Pharmaceuticals Business Overview
Table 119. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 120. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026
Table 121. Ironwood Pharmaceuticals Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report


List of Figures
Figure 1. Sickle Cell Anemia Therapeutics Picture
Figure 2. Global Sickle Cell Anemia Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. Blood Transfusion Features
Figure 5. Pharmacotherapy Features
Figure 6. Bone Marrow Transplant Features
Figure 7. Global Sickle Cell Anemia Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2025 vs 2032
Figure 9. Child Case Studies
Figure 10. Adult Case Studies
Figure 11. Sickle Cell Anemia Therapeutics Report Years Considered
Figure 12. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2025 vs 2032
Figure 15. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2025
Figure 16. Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2025
Figure 18. North America Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)
Figure 20. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)
Figure 24. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Region (2021–2032)
Figure 32. China Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)
Figure 40. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)
Figure 44. Israel Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 48. Theravia Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 49. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 50. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 51. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 52. Novo Nordisk Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 53. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 54. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 55. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 56. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 57. Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 58. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 59. Bioverativ Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 60. Imara Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 61. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies